ARDUINI; Arduino

Patent Applications and Registrations

Patent applications and USPTO patent grants for ARDUINI; Arduino.The latest application filed is for "composition comprising citrate and carnitine able to activate the production of the protein klotho".

Company Profile

0.12.15

ARDUINI; Arduino - Arogno TI
ARDUINI; Arduino - Arogno CH
ARDUINI; Arduino - Chieti IT
Arduini; Arduino - San Giovanni Teatino N/A IT
Arduini; Arduino - Rome IT
Arduini; Arduino - Pescara IT
Arduini; Arduino - San Giovanni Teatino Chieti
Arduini; Arduino - Roma IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition Comprising Citrate And Carnitine Able To Activate The Production Of The Protein Klotho App 20220241235 - CASTELLANO; Giuseppe ; et al.	2022-08-04
Peritoneal Dialysis Solution App 20210361844 - ARDUINI; Arduino ; et al.	2021-11-25
Connecting Device App 20160129236 - ARRIZZA; Fabio ; et al.	2016-05-12
Connection Device App 20150151102 - Arduini; Arduino ; et al.	2015-06-04
Coupling device Grant 8,992,508 - Arduini , et al. March 31, 2	2015-03-31
Coupling device and use thereof Grant 8,518,015 - Arduini , et al. August 27, 2	2013-08-27
Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use Grant 7,932,291 - Arduini April 26, 2	2011-04-26
Method of reducing glycolysis in platelet concentrates using L-carnitine, alkanoyl carnitines and salts thereof Grant 7,851,142 - Dottori , et al. December 14, 2	2010-12-14
Coupling Device And Use Thereof App 20100292633 - Arduini; Arduino ; et al.	2010-11-18
Coupling Device App 20100286625 - Arduini; Arduino ; et al.	2010-11-11
Method for inhibiting bacterial growth in a leuko-reduced platelet concentrate by adding L-carnitine Grant 7,816,073 - Dottori , et al. October 19, 2	2010-10-19
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase Grant RE41,226 - Giannessi , et al. April 13, 2	2010-04-13
Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure App 20090221701 - Arduini; Arduino	2009-09-03
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase Grant RE40,861 - Giannessi , et al. July 21, 2	2009-07-21
Carnitine-Containing Peritoneal Dialysis Solution Having Improved Biocompatibility App 20080138443 - Arduini; Arduino	2008-06-12
Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation App 20080027098 - Giannessi; Fabio ; et al.	2008-01-31
Storage And Maintenance Of Blood Products Including Red Blood Cells And Platelets App 20070248941 - DOTTORI; Secondo ; et al.	2007-10-25
Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use App 20050085542 - Arduini, Arduino	2005-04-21
Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use Grant 6,822,002 - Arduini November 23, 2	2004-11-23
Solution for the storage and perfusion of organs awaiting transplantation App 20040156990 - Arduini, Arduino ; et al.	2004-08-12
Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure App 20030176499 - Arduini, Arduino	2003-09-18
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase Grant 6,444,701 - Giannessi , et al. September 3, 2	2002-09-03
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase App 20020052348 - Giannessi, Fabio ; et al.	2002-05-02
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase Grant 6,369,073 - Giannessi , et al. April 9, 2	2002-04-09
Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia App 20020002202 - Cavazza, Claudio ; et al.	2002-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.